Ricerca di contatti, progetti,
corsi e pubblicazioni

CHAPERONE - Allosteric chaperones to treat rare lysosomal storage disorders

Persone

 

Molinari M.

(Responsabile)

Abstract

The consortium will deliver proof-of-concept (PoC) data for a novel class of therapeutic molecules to treat rare lysosomal storage disorders (LSD), for which no cure exists. A computational platform that identifies unique allosteric enzyme binding sites has generated novel compounds to restore the function of LSD-causing defects in enzymes. During the project the efficacy to restore enzyme function will be validated resulting in a data package including efficacy and mode-of-action.

Informazioni aggiuntive

Acronimo
CHAPERONE
Data d'inizio
01.10.2019
Data di fine
31.10.2022
Durata
37 Mesi
Enti finanziatori
Confederazione svizzera
Stato
In corso
Categoria
European and International Programmes / Horizon 2020 / Collaborative projects - ICT